Partners Bancorp (PTRS): Stock Price, Earnings & Key Metrics

This asset is no longer available for investment.

View all assets

Price

return (12m)

0.00%

p/e

8.12

p/bv

0.90

DIVIDEND YIELD

2.32%

PTRS price

Partners Bancorp

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PTRS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals PTRS

Valuation

P/E

8.12

Sector -4.03

Industry -4.03

P/BV

0.90

Sector 2.05

Industry 2.05

P/Revenue (PSR)

1.94

Sector -4.26

Industry -4.26

EV/EBITDA

1.77

Sector -238.32

Industry -238.32

EV/EBIT

1.77

Sector -670.55

Industry -670.55

P/EBITDA

4.97

Sector -4.23

Industry -4.23

P/EBIT

4.97

Sector -4.29

Industry -4.29

P/Total Assets

0.08

Sector 1.45

Industry 1.45

P/Ativo Circ. Liq.

Sector -11.51

Industry -11.51

P/Cap.Giro

Sector -11.45

Industry -11.45

EPS

0.88

Sector -2.20

Industry -2.20

BVPS

7.95

Sector 1.95

Industry 1.95

Efficiency

Gross Margin

73.53%

Sector 36.28%

Industry 36.28%

EBITDA Margin

36.89%

Sector -16,822.56%

Industry -16,822.56%

EBIT Margin

36.89%

Sector -4,238,732.42%

Industry -4,238,732.42%

Operating Margin

27.77%

Sector -38.78%

Industry -38.78%

Net Profit Margins

23.92%

Sector -39.92%

Industry -39.92%

Giro Ativos

0.01

Sector 0.03

Industry 0.03

Profitability

ROE

11.07%

Sector -65.93%

Industry -65.93%

ROA

1.03%

Sector -66.10%

Industry -66.10%

ROIC

Sector -2,918.81%

Industry -2,918.81%

Dividends

Dividend yield

2.32%

Sector -

Industry -

Payout

18.84%

Sector -

Industry -

Debt

Current Ratio

Sector 2.91

Industry 2.91

Dívida Líquida/EBITDA

-19.54

Sector -13,526,126.12

Industry -13,526,126.12

Dívida Líquida/EBIT

-19.54

Sector -3.66

Industry -3.66

Dívida Líquida/Patrimônio

-0.82

Sector -1.10

Industry -1.10

Dívida Bruta/Patrimônio

0.30

Sector -0.10

Industry -0.10

Equity/Assets

0.09

Sector 0.42

Industry 0.42

Liabilities/Assets

0.09

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

3.87%

Sector -

Industry -

5Y Earnings CAGR

16.41%

Sector -

Industry -

FAIR VALUE OF Partners Bancorp ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.00

Fair Value

$12.55

Upside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals PTRS

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
PTRS	8.12	0.90	11.07%	2.32%	$128.77 M	23.92%
JNJ	30.06	7.44	24.76%	1.99%	$632.34 B	21.48%
PFE	18.39	1.52	8.29%	7.11%	$137.74 B	11.83%
ABBV	126.05	-69.30	-54.98%	2.60%	$458.19 B	5.79%
NVO	11.48	6.93	60.40%	3.79%	$217.68 B	37.15%
MRK	36.33	7.07	19.45%	2.56%	$324.61 B	13.59%
AZN	25.14	5.51	21.93%	1.90%	$261.15 B	17.19%
GILD	17.54	6.90	39.33%	2.47%	$161.64 B	30.99%
BMY	17.28	6.25	36.19%	4.05%	$125.69 B	15.01%
ZTS	11.99	9.80	81.75%	2.74%	$31.69 B	27.79%
REGN	15.66	2.20	14.08%	0.55%	$69.27 B	29.65%
HALO	27.62	43.86	158.82%	0.00%	$9.63 B	23.13%
AMGN	26.05	22.11	84.87%	2.60%	$203.18 B	20.96%
MCK	21.59	-123.30	-570.98%	0.39%	$102.83 B	1.18%
VRTX	28.04	6.28	22.41%	0.00%	$121.66 B	35.51%
CAH	34.58	-20.13	-58.20%	0.89%	$53.78 B	0.62%
HRMY	14.10	2.26	16.00%	0.00%	$2.05 B	16.20%
BIIB	21.68	1.59	7.36%	0.00%	$29.75 B	13.81%
MEDP	34.42	38.99	113.29%	0.00%	$16.92 B	17.67%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PTRS Historical Dividends

current DY: 2.32%

5-year average DY: 1.93%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	11/16/2023	11/27/2023	0.08600000
Dividends	08/08/2023	08/17/2023	0.04000000
Dividends	05/08/2023	05/17/2023	0.04000000
Dividends	02/06/2023	02/15/2023	0.04000000
Dividends	11/07/2022	11/17/2022	0.04000000
Dividends	08/08/2022	08/19/2022	0.02500000
Dividends	05/09/2022	05/16/2022	0.02500000
Dividends	02/04/2022	02/15/2022	0.02500000
Dividends	12/20/2021	12/30/2021	0.02500000
Dividends	09/22/2021	10/01/2021	0.02500000
Dividends	06/22/2021	07/01/2021	0.02500000
Dividends	03/22/2021	04/01/2021	0.02500000
Dividends	12/22/2020	01/02/2021	0.02500000
Dividends	09/24/2020	10/05/2020	0.02500000
Dividends	06/24/2020	07/03/2020	0.02500000

ABOUT Partners Bancorp

Partners Bancorp

Average Investor10 user rating

4.0 (2 people)

United States

38 years

Founded: 1988

2020

Time since IPO - 6 years

220

Employees

Partners Bancorp (United States) is listed on the Nasdaq and has a market capitalization of $128.77 million, with shareholders equity totaling $143.14 million.

The company employs approximately 220 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Partners Bancorp reported $66.26 million in revenue, generating net income of $15.85 million.

Key financial metrics include a P/E ratio of 8.12, a price-to-book (P/B) ratio of 0.90, and a trailing twelve-month dividend yield of 2.32%.

The company trades under the ticker PTRS.

Market cap

$128.77 million

Net worth

$143.14 million

$143,143,635.00

Assets

$1.53 billion

$1,533,033,525.00

Total Shares Outstanding

18.01 million

18,009,000

Average Daily Trading Volume

$11.17 Thousand

$11,173.16

Sector

Health Care

Industry

Biotechnology

PTRS

PTRS revenue and profits

Financial Results PTRS

DRAG THE FRAME TO SEE MORE DATA

PTRS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$850.06 20,98% (12M)

P/E

21.59

0.39%

ROE

-570.98%

P/BV

-123.30

CAH - Cardinal Health

$229.35 48,25% (12M)

P/E

34.58

0.89%

ROE

-58.20%

P/BV

-20.13

JNJ - Johnson & Johnson

$265.95 64,85% (12M)

P/E

30.06

1.99%

ROE

24.76%

P/BV

7.44

MRK - Merck & Co.

$130.76 60,71% (12M)

P/E

36.33

2.56%

ROE

19.45%

P/BV

7.07

AZN - AstraZeneca

$169.64 16,66% (12M)

P/E

25.14

1.90%

ROE

21.93%

P/BV

5.51

ABBV - AbbVie

$256.91 41,83% (12M)

P/E

126.05

2.60%

ROE

-54.98%

P/BV

-69.30

NVO - Novo Nordisk

$49.67 --3,46% (12M)

P/E

11.48

3.79%

ROE

60.40%

P/BV

6.93

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$850.06 20,98% (12 M)

P/L

21.59

0.39%

ROE

-570.98%

P/VP

-123.30

CAH - Cardinal Health

$229.35 48,25% (12 M)

P/L

34.58

0.89%

ROE

-58.20%

P/VP

-20.13

JNJ - Johnson & Johnson

$265.95 64,85% (12 M)

P/L

30.06

1.99%

ROE

24.76%

P/VP

7.44

MRK - Merck & Co.

$130.76 60,71% (12 M)

P/L

36.33

2.56%

ROE

19.45%

P/VP

7.07

AZN - AstraZeneca

$169.64 16,66% (12 M)

P/L

25.14

1.90%

ROE

21.93%

P/VP

5.51

ABBV - AbbVie

$256.91 41,83% (12 M)

P/L

126.05

2.60%

ROE

-54.98%

P/VP

-69.30

NVO - Novo Nordisk

$49.67 --3,46% (12 M)

P/L

11.48

3.79%

ROE

60.40%

P/VP

6.93

Frequently Asked Questions

What is the price of Partners Bancorp (PTRS) today?

A cotação de Partners Bancorp (PTRS) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Partners Bancorp (PTRS) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Partners Bancorp (PTRS) e dados de ações do Ibovespa e mercados internacionais.

Quando Partners Bancorp (PTRS) paga dividendos?

Partners Bancorp (PTRS) não distribuiu dividendos no último ano.

Is Partners Bancorp (PTRS) a good investment?

Atualmente, Partners Bancorp (PTRS) está cotada a US$ 0.00, com um P/L de 8.12, representando um desvio de 976% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 2.32%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Partners Bancorp (PTRS) stock?

Investir em ações de Partners Bancorp (PTRS) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Partners Bancorp (PTRS) yield today?

A rentabilidade de Partners Bancorp (PTRS) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 2.32%.

Se você quisesse comprar 100 ações de Partners Bancorp (PTRS) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

PTRS

Partners Bancorp

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment PTRS

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

current DY: 2.32%

5-year average DY: 1.93%

type

Ex - Dividend Date

payment date

value

ABOUT Partners Bancorp

Partners Bancorp

United States

38 years

2020

220

PROFIT X PRICE PTRS

Financial Results PTRS

PTRS cash flow

Asset, Revenue and Profit Growth - PTRS

PTRS balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions